Cardiovascular System

To visit the main Medicines Optimisation Guidance page please click here.

Heart Failure

• Information Sheet – Sacubitril / Valsartan

Lipid Management

• National Guidance for Lipid Management for Primary and Secondary Prevention of CVD
• Inclisiran Dispensing Options Flowchart
• Inclisiran Patient Leaflet

New Oral Anticoagulants (NOAC)

The new oral Anticoagulants, Rivaroxaban, Dabigatran and Apixaban are now available for initiation in primary care and in limited circumstances for inpatients in secondary care.  The drugs are grey listed  and must be used within the criteria specified; the grey list can be accessed by clicking here.

A range of documents have been developed to support clinicians in considering these medications and help and support is available from the Medicines Management Team, either through the prescribing enquiry e-mail stoccg.pxenquiries@nhs.net or via telephone on 0161 426 9910.

Individual summary of product characteristics can be accessed by searching on the drug name at this website http://www.medicines.org.uk/EMC

NOAC Documentation

• For GMMMG guidance on prescribing NOACs click here
• Referral pathway for NOAC drugs
• Record of Inititaion NOAC in AF
• Outpatient Flowchart
• Patient Counselling checklist
• Leaflet Rivaroxaban for DVT
• Leaflet Dabigatran for AF
• Leaflet Rivaroxaban in AF
• Leaflet Apixaban in AF
• Leaflet Rivaroxaban for PE
• NOAC transfer for DVT PE
• NOAC transfer process for AF patients
• GMMMG Prescriber Support Tool DOACs in Adults
• National Guidance for Lipid Management for Primary and Secondary Prevention of CVD
• Inclisiran Dispensing Options Flowchart
• Inclisiran Patient Leaflet